# Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors

> **NCT01653041** · PHASE4 · COMPLETED · sponsor: **Hospital do Rim e Hipertensão** · enrollment: 47 (actual)

## Conditions studied

- Kidney Transplantation

## Interventions

- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01653041
- **Lead sponsor:** Hospital do Rim e Hipertensão
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2014-08
- **Final completion:** 2015-04
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2016-08-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01653041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01653041, "Certican (Everolimus) for Recipients of Kidney From HLA-identical Living Donors". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01653041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*